Clinical data further supports the effectiveness of EXOMIND. In a recent IRB-approved clinical trial, 83% of patients diagnosed with depression reported feeling less depressed three months after their ...
The study will examine the safety and efficacy of Sooma Medical's device, Sooma 2GEN, in improving MDD as a home-based treatment. The device, worn as a cap, uses tDCS therapy, a non-invasive technique ...
DONGGUAN, GUANGDONG, CHINA, January 22, 2026 /EINPresswire.com/ — As global healthcare systems increasingly emphasize preventive care and home-based health management, non-invasive sleep and ...
Professional services consultancy, Procorre is urging the Medical Devices industry to take action ahead of the new ISO13485:2016 International Standard and MDD & IVD ‘Recast’ which become mandatory in ...
Can New Devices be Approved from Single Arm Studies: Use of Real-World Data as an External Control Group or for Propensity Matching or Generating Objective Performance Criteria Receive the the latest ...
BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Sooma Medical, a world-leading provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results